Attenuated african swine fever virus and use thereof in vaccine compositions

Attenuated african swine fever virus and use thereof in vaccine compositions

The present invention relates to African Swine Fever (ASF) attenuated viruses wherein the genes EP402R and EP153R have been inactivated, which can be used as a vaccine. The attenuated viruses protect pigs against subsequent challenge with virulent virus. The present invention also relates to the use of such attenuated viruses to treat and/or prevent ASF

Saved in:
Bibliographic Details
Main Authors: Van den Born, Erwin, Arias, Marisa, Gallardo, Carmina, Fernández-Pinero, Jovita, Zádori, Zoltán, Mészáros, István, Olasz, Ferenc, Sánchez-Vizcaíno, J. M., Barroso Arévalo, Sandra, Barasona García-Arévalo, José Ángel, Kosowska, Aleksandra, Rueda Pérez, Paloma
Format: solicitud de patente biblioteca
Language:English
Published: 2024-05-30
Online Access:http://hdl.handle.net/10261/367915
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The present invention relates to African Swine Fever (ASF) attenuated viruses wherein the genes EP402R and EP153R have been inactivated, which can be used as a vaccine. The attenuated viruses protect pigs against subsequent challenge with virulent virus. The present invention also relates to the use of such attenuated viruses to treat and/or prevent ASF

Similar Items